Lack of estrogen receptor associated with an increased response rate to cytotoxic chemotherapy in metastatic breast cancer?
作者信息
Lippman M E, Allegra J C
出版信息
Recent Results Cancer Res. 1980;71:155-61. doi: 10.1007/978-3-642-81406-8_24.
PMID:7367728
Abstract
摘要
相似文献
1
Lack of estrogen receptor associated with an increased response rate to cytotoxic chemotherapy in metastatic breast cancer?雌激素受体缺乏与转移性乳腺癌对细胞毒性化疗的反应率增加有关？
Recent Results Cancer Res. 1980;71:155-61. doi: 10.1007/978-3-642-81406-8_24.
2
The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.雌激素和孕激素受体水平与晚期乳腺癌化疗反应的相关性
Surg Gynecol Obstet. 1981 Jan;152(1):70-4.
3
Principles and indications of endocrine treatment of advanced breast cancer.晚期乳腺癌内分泌治疗的原则与指征
Recent Results Cancer Res. 1980;71:112-7. doi: 10.1007/978-3-642-81406-8_15.
4
Therapeutic effect of tamoxifen related to estrogen receptor level.他莫昔芬的治疗效果与雌激素受体水平相关。
Recent Results Cancer Res. 1980;71:134-41. doi: 10.1007/978-3-642-81406-8_19.
5
Endocrine ablation for metastatic breast cancer: a reappraisal of hormone receptors.转移性乳腺癌的内分泌消融：激素受体的重新评估
Am J Surg. 1980 Jul;140(1):164-72. doi: 10.1016/0002-9610(80)90435-3.
6
Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval.定量雌激素受体分析：人类乳腺癌对内分泌和细胞毒性化疗的反应及无病生存期。
Cancer. 1980 Dec 15;46(12 Suppl):2829-34. doi: 10.1002/1097-0142(19801215)46:12+<2829::aid-cncr2820461419>3.0.co;2-m.
7
Relationship of quantitative estrogen-receptor level and clinical response to cytotoxic chemotherapy in advanced breast cancer. An extramural analysis.晚期乳腺癌中雌激素受体定量水平与细胞毒性化疗临床反应的关系。一项外部分析。
Cancer. 1984 Oct 15;54(8):1554-61. doi: 10.1002/1097-0142(19841015)54:8<1554::aid-cncr2820540815>3.0.co;2-4.
8
Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):763-6.
9
Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer.
Cancer. 1981 Dec 1;48(11):2503-6. doi: 10.1002/1097-0142(19811201)48:11<2503::aid-cncr2820481126>3.0.co;2-t.
10
Estrogen receptors and breast cancer: prognostic and therapeutic implications.雌激素受体与乳腺癌：预后及治疗意义
Surgery. 1980 Sep;88(3):386-93.
引用本文的文献
1
Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review.氟维司群治疗激素受体阳性/人表皮生长因子受体 2 阴性晚期乳腺癌：综述。
Cancer Med. 2019 May;8(5):1943-1957. doi: 10.1002/cam4.2095. Epub 2019 Apr 19.
2
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.预测局部晚期（T4）乳腺癌患者早期治疗失败的因素。
Br J Cancer. 2008 Jun 3;98(11):1745-52. doi: 10.1038/sj.bjc.6604384. Epub 2008 May 27.
Zotero 插件